華森製藥(002907.SZ):鋁碳酸鎂片及阿魏酸鈉獲藥品再註冊批件
格隆匯3月9日丨華森製藥(002907.SZ)公佈,公司於近日收到重慶市藥品監督管理局核准簽發的公司2個產品的“藥品再註冊批件”。
藥品1通用名稱:鋁碳酸鎂片;商品名:威地美;劑型:片劑;規格:0.5g;審批結論:經審查,本品符合《藥品註冊管理辦法》的有關規定,同意再註冊。
藥品2通用名稱:阿魏酸鈉;劑型:原料藥;審批結論:經審查,同意本品再註冊。由於本品長期未生產,恢復生產時,須向市藥監局提出現場檢查申請,經市藥監局現場檢查並抽驗一批產品合格。
威地美(鋁碳酸鎂片):胃及十二指腸潰瘍,急慢性胃炎,膽汁反流性胃炎,食管炎,以及非潰瘍性消化不良。症見胃灼痛、反酸、燒心、飽脹、早飽、噁心、嘔吐等。阿魏酸鈉(原料藥):用於生產注射用阿魏酸鈉。
上述藥品再註冊批件的取得確保了公司上述藥品的正常生產和銷售,公司將嚴格按照要求開展相應工作,控制產品質量,持續為市場提供高品質的產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.